Form 8-K - Current report:
SEC Accession No. 0000950170-25-090616
Filing Date
2025-06-27
Accepted
2025-06-27 08:15:27
Documents
10
Period of Report
2025-06-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rare-20250627.htm   iXBRL 8-K 49670
  Complete submission text file 0000950170-25-090616.txt   152788

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rare-20250627.xsd EX-101.SCH 23898
12 EXTRACTED XBRL INSTANCE DOCUMENT rare-20250627_htm.xml XML 4516
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 251082301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)